The Opioid Use Disorder Market has shown significant growth, with a valuation of USD 3.13 billion in 2022. Projections indicate substantial expansion, with expectations reaching around USD 6.15 billion by 2030. This growth underscores the escalating prevalence of opioid use disorder globally and the pressing need for effective treatments and interventions. With a remarkable compound annual growth rate (CAGR) of 8.8% over the forecast period from 2023 to 2030, the market is poised for considerable development, driven by factors such as increasing awareness, expanding treatment options, and efforts to address the opioid crisis through comprehensive healthcare strategies and policies.